Resonant frequency therapy devices deliver low power pulsed electromagnetic energy to living tissues for use as therapy. The resultant energy waves have proven successful at inhibiting microbial growth and treating diseases and affected tissue. Positive responses have been seen with therapeutic resonant frequencies linked to specific genes or messenger RNA codes coding proteins associated with specific proteins.
Methods for determining therapeutic resonant frequencies
Therapeutic resonant frequencies must be identified to influence genomic materials such as DNA and RNA, but determining them requires both ease and efficiency. Efficient methods should allow these frequencies to be programmed into frequency-emitting devices like electromagnetic, magnetic, plasma, audio or light waves for programming into frequency emitting devices that will use these frequencies to either inhibit, debilitate or stimulate biophysical processes depending on what device and delivery system are being utilized with therapeutic resonant frequencies. The effectiveness of therapeutic resonant frequencies depends to some degree on both these aspects when combined with appropriate devices and delivery systems used alongside them – their effectiveness often depends on these factors alone!
The present invention employs an original method for identifying therapeutic resonant frequencies. It relies on the fact that objects possess natural resonant frequencies which correlate to their length and manifest themselves into their surroundings; an object’s length determines its natural resonant frequency which manifests into its environment – for instance DNA/RNA chains provide a good example; their length can be converted to frequency by multiplying base pair spacing by multiplying wavelength times frequency.
This technique can also be utilized for determining subharmonic frequencies, which are multiples of the fundamental frequency. Subharmonic frequencies offer more effective means of modulating genetic activity than just fundamental frequency alone and are more easily accessible via current devices. Furthermore, using this method allows multiple frequencies to be simultaneously released thereby increasing both their effectiveness and efficiency.
Many devices such as modulated shortwave diathermy, infrasound units and resonant frequencies have been designed with the intent of improving tissue acceptance and penetration by therapeutic wave forms. Unfortunately, all these devices present significant limitations; the present invention addresses these shortcomings by including harmonics within its device design.
This patented device uses low-power radio frequency (RF) waves to effectively disrupt and kill cancer cells during mitosis, shrinking tumors while killing cancerous ones. Designed not to harm healthy cells and tissues, this solution can be applied across many medical conditions including inflammation diseases, infections and cancer.
This device works by shaping an overmodulated radio wave pulse from a transmitter and sending it down a gas filled tube, where its waves resonate with and couple to all tissues in the body to produce physiological effects.
Methods for determining subharmonic frequencies
The invention presents methods for identifying subharmonic frequencies. These frequencies may be determined by dividing the fundamental frequency of a frequency-generating device by its power factor or multiples thereof, with applications across electromagnetic, plasma, audio and magnetic frequency emitters such as genomic material resonant frequencies being readily and efficiently identified through trial-and-error rather than simply trialing frequencies with genomic material.
This innovative device can generate compressional pulses inside cells and organisms by modulating an electromagnetic pulse with an audio frequency, producing waves with wavelengths reaching well into ultrasonic range. Furthermore, each compressional pulse has its own PRR related to its modulation frequency – creating compressional waves capable of exerting compressional forces within living organisms.
Additionally, this device can produce standing waves with cells and organisms – an invaluable capability that enables it to produce more powerful effects than those generated by existing devices. Furthermore, its improved efficiency exceeds that of its counterparts by using lower pulse repetition rates while producing equal output power outputs.
An additional advantage of the improved device is that it produces much larger instantaneous electromotive force (EMF) changes when cutting conductors with its magnetic field emission pulse. For instance, cutting with one at 300Hz output pulse frequency results in instantaneous EMF changes of over 10,000 times; by comparison existing devices only manage an equivalent effect at this same pulse frequency.
The patented device also offers greater diagnostic and therapeutic flexibility by enabling users to select an ideal resonant frequency for various genomic materials. Users can identify resonant frequencies for genes, smaller portions of DNA and constituent components within genomic material in order to induce therapeutic responses within the body and monitor whether genetic therapy treatments are working effectively for patients.
Methods for determining a first therapeutic resonant frequency
Methods provided in the invention enable identification of therapeutic or beneficial resonant frequencies that can be utilized in treating human and animal ailments and diseases. Furthermore, the methods provided by this invention facilitate faster and simpler identification of therapeutic or beneficial resonant frequencies for genes, gene sections and constituent components of genomic materials. The methods of the invention also take into account an appropriate electromagnetic refractive index for any given medium and then shift any resonant frequencies determined to ranges that can be produced by existing electromagnetic, magnetic, plasma, audio or light emitting devices.
To obtain an audio range resonant frequency that corresponds to a first therapeutic resonant frequency, divide its initial therapeutic resonant frequency by 2 or some power of 2, until a resonant frequency in that range can be identified. Frequencies related by factors of 2, such as 2 or some power of 2, are known as octaves in music; when applied to therapeutic resonance frequencies they will resonate similarly – just as musical octaves do.
According to this invention, a genomic material’s initial therapeutic resonant frequency is moved down an octave in electromagnetic spectrum by dividing it by some power of 2. This lower octave has longer wavelength than its first cousin and will therefore resonate with and amplify each other like musical octaves do.
The method of the invention involves creating an overmodulated radio wave pulse in a frequency-generating device and outputting it through a gas filled tube, where its energy wave form will penetrate all tissues within the body to produce physiological effects in accordance with its audio frequency. Unlike previous methods for applying audio frequencies to human bodies, this one offers multiple wave energies which may help treat various medical conditions; furthermore it can easily integrate into existing devices like MRI machines.
Methods for determining a second therapeutic resonant frequency
An approach for identifying therapeutic resonant frequencies is presented here. The method works on the principle that each genomic material has its own resonant frequency, which manifests as wavelength in surrounding medium. Lengths of biomolecular chains containing DNA or RNA can be determined, then their resonant frequency measured; then by multiplying by an integer positive integer multiples this value, harmonic frequencies and subharmonic frequencies can be identified.
Researchers investigating the resonant frequencies of bacteria have discovered that specific frequencies are associated with its inhibition, suggesting therapeutic resonant frequencies may help prevent or treat various diseases; yet their exact mechanisms remain unknown.
To determine resonant frequency, a 2 mm-diameter gold marker was placed into a water phantom with the beam axis as its central point and its resonant frequency determined to be 1.62 MHz. Resonance signal was observed using two hydrophones: V397-SU for one hydrophone while an LFH equipped with piezoelectric ceramic for increased sensitivity was used for another (Fig 4a shows the waveform of this latter signal generated by an LFH). Corrected for systematic errors of up to 0.8 mm caused by incorrect positioning between hydrophones and markers for another.
Resonant frequency was associated with several heart rate variability (HRV) parameters, including average interval time between beats and lowest respiratory sinus arrhythmia, commonly referred to as RSA. Furthermore, its association was confirmed with mean of nearby below and above rates. Resonant frequencies were found to correlate significantly with treatment outcomes; specifically, subjects ranked highly for 10Hz as their resonant frequency saw the most improvement in HRV measures after receiving rTMS at this frequency. Results indicate that within-subject ranking of resonant frequencies may be useful in identifying an effective stimulation frequency to treat specific disorders; however, further study is necessary to investigate biophysical and biochemical mechanisms relating effective therapeutic frequencies to microbial inhibition.
